©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 112046
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112046
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112046
Figure 3 Apixaban levels and clotting time-post evaluation across the four drug dosage groups.
A: Distribution of apixaban plasma concentrations across prescribed dose groups, displayed as box-and-whisker plots. Boxes represent the interquartile range with the median shown as a horizontal line; whiskers indicate values within 1.5 × interquartile range, and points beyond are outliers; B: Post-drug clotting time (clotting time-post) values across apixaban dose groups, presented as box-and-whisker plots. Boxes represent the interquartile range with the median shown as a horizontal line, whiskers indicate values within 1.5 × interquartile range, and points beyond are outliers; C: Post-treatment clotting time (clotting time-post) mean values across apixaban dose groups, further stratified by the presence or absence of bleeding events. CT: Clotting time.
- Citation: Bacharaki D, Kyriakou E, Sardeli A, Nikolopoulos P, Triantaphyllis G, Drakou A, Makris F, Spanou E, Triantou E, Haviaras E, Fatourou A, Poulis A, Tsantes A, Kyriazis J, Lionaki S. Bleeding prediction by rotational thromboelastometry in chronic hemodialysis patients with non-valvular atrial fibrillation on apixaban. World J Cardiol 2025; 17(12): 112046
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/112046.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.112046